Systemic inflammation in childhood obesity: Circulating inflammatory mediators and activated CD14++ monocytes

Diabetologia

Volumn 55, Issue 10, 2012, Pages 2800-2810

  Schipper, H S ^a,b   Nuboer, R ^c   Prop, S ^a   Van Den Ham, H J ^d   De Boer, F K ^e   Kesmir, C ^e   Mombers, I M H ^b   Van Bekkum, K A ^b   Woudstra, J ^a   Kieft, J H ^b   Hoefer, I E ^a   De Jager, W ^b   Prakken, B ^b   Van Summeren, M ^b   Kalkhoven, E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MEANDER MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Adipokines; Childhood obesity; Inflammation; Insulin resistance; Monocytes

Indexed keywords

ADIPOCYTOKINE; CD14 ANTIGEN; CHEMERIN; EPIDERMAL GROWTH FACTOR; INSULIN; LEPTIN; LIGAND; LIPOPOLYSACCHARIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADIPOCYTOKINE BLOOD LEVEL; ADOLESCENT; ARTICLE; CD14+ MONOCYTE; CELL ACTIVATION; CELL COUNT; CELL FUNCTION; CELL SUBPOPULATION; CHILD; CHILDHOOD OBESITY; CLUSTER ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC DISEASE; SYSTEMIC INFLAMMATION;

ADOLESCENT; ANTIGENS, CD14; CASE-CONTROL STUDIES; CELL COUNT; CHEMOKINES; CHILD; CLUSTER ANALYSIS; COMORBIDITY; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LEPTIN; MALE; MONOCYTES; OBESITY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REGRESSION ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84866071750     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2641-y     Document Type: Article

References (49)

1. Lumeng CN, Saltiel AR (2011) Inflammatory links between obesity and metabolic disease. J Clin Invest 121:2111-2117
2. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860-867 (Pubitemid 46024993)
3. Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85-97
4. Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98-107
5. Rocha VZ, Libby P (2009) Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 6:399-409
6. Li S, Shin HJ, Ding EL, van Dam RM (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302:179-188
7. Kullo IJ, Hensrud DD, Allison TG (2002) Comparison of numbers of circulating blood monocytes in men grouped by body mass index (<25, 25 to <30, > or =30). Am J Cardiol 89:1441-1443 (Pubitemid 34607793)
8. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P (2004) Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 110:1564-1571 (Pubitemid 39297977)
9. Ziegler-Heitbrock L (2007) The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 81:584-592 (Pubitemid 46393535)
10. Wong KL, Tai JJ, Wong WC et al (2011) Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118:e16-e31
11. Zawada AM, Rogacev KS, Rotter B et al (2011) SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 118:e50-e61
12. Poitou C, Dalmas E, Renovato M et al (2011) CD14dimCD16+ and CD14∈+∈CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis. Arterioscler Thromb Vasc Biol 31:2322-2330
13. Rogacev KS, Ulrich C, Blomer L et al (2010) Monocyte heterogeneity in obesity and subclinical atherosclerosis. Eur Heart J 31:369-376
14. Satoh N, Shimatsu A, Himeno A et al (2010) Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone. Diabetes Care 33:e7
15. Tam CS, Clement K, Baur LA, Tordjman J (2010) Obesity and low-grade inflammation: a paediatric perspective. Obes Rev 11:118-126
16. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (2001) Low-grade systemic inflammation in overweight children. Pediatrics 107:E13
17. Skinner AC, Steiner MJ, Henderson FW, Perrin EM (2010) Multiple markers of inflammation and weight status: cross-sectional analyses throughout childhood. Pediatrics 125:e801-e809
18. Tam CS, Garnett SP, Cowell CT et al (2010) IL-6, IL-8 and IL-10 levels in healthy weight and overweight children. Horm Res Paediatr 73:128-134
19. Tirosh A, Shai I, Afek A et al (2011) Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med 364:1315-1325
20. Lloyd LJ, Langley-Evans SC, McMullen S (2012) Childhood obesity and risk of the adult metabolic syndrome: a systematic review. Int J Obes (Lond) 36:1-11
21. Schipper HS, de Jager W, van Dijk ME et al (2010) A multiplex immunoassay for human adipokine profiling. Clin Chem 56:1320-1328
22. Heimbeck I, Hofer TP, Eder C et al (2010) Standardized single-platform assay for human monocyte subpopulations: lower CD14∈+∈CD16++ monocytes in females. Cytometry A 77:823-830
23. Schonbeck Y, Talma H, van Dommelen P et al (2011) Increase in prevalence of overweight in Dutch children and adolescents: a comparison of nationwide growth studies in 1980, 1997 and 2009. PLoS One 6:e27608
24. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240-1243 (Pubitemid 30240471)
25. Kondaki K, Grammatikaki E, Pavon DJ et al (2011) Comparison of several anthropometric indices with insulin resistance proxy measures among European adolescents: The Helena Study. Eur J Pediatr 170:731-739
26. Lawlor DA, Fraser A, Lindsay RS et al (2010) Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort. Diabetologia 53:89-97
27. Verrijn Stuart AA, Schipper HS, Tasdelen I et al (2012) Altered plasma adipokine levels and in vitro adipocyte differentiation in pediatric type 1 diabetes. J Clin Endocrinol Metab 97:463-472
28. Scholtes VP, Versteeg D, de Vries JP et al (2011) Toll-like receptor 2 and 4 stimulation elicits an enhanced inflammatory response in human obese patients with atherosclerosis. Clin Sci (Lond) 121:205-214
29. Benjamini Y, Hochberg Y (1995) Controlling the false discovery ratea practical and powerful approach to multiple testing. J Roy Stat Soc B Methodological 57:289-300
30. van den Ham HJ, de Jager W, Bijlsma JW, Prakken BJ, de Boer RJ (2009) Differential cytokine profiles in juvenile idiopathic arthritis subtypes revealed by cluster analysis. Rheumatol (Oxford) 48:899-905
31. Teom RDC (2011) R: a language environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria
32. Suzuki R, Shimodaira H (2006) Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22:1540-1542 (Pubitemid 43985330)
33. Chen H, Sullivan G, Quon MJ (2005) Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 54:1914-1925 (Pubitemid 40911252)
34. Gunczler P, Lanes R (2006) Relationship between different fasting-based insulin sensitivity indices in obese children and adolescents. J Pediatr Endocrinol Metab 19:259-265
35. Garcia-Mayor RV, Andrade MA, Rios M, Lage M, Dieguez C, Casanueva FF (1997) Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage. J Clin Endocrinol Metab 82:2849-2855 (Pubitemid 27385638)
36. Gautier EL, Jakubzick C, Randolph GJ (2009) Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arterioscler Thromb Vasc Biol 29:1412-1418
37. Boschmann M, Engeli S, Adams F et al (2005) Adipose tissue metabolism and CD11b expression on monocytes in obese hypertensives. Hypertension 46:130-136 (Pubitemid 40946503)
38. Ernst MC, Sinal CJ (2010) Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 21:660-667
39. Gupta A, Ten S, Anhalt H (2005) Serum levels of soluble tumor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children. J Pediatr Endocrinol Metab 18:75-82 (Pubitemid 40227875)
40. Meissburger B, Stachorski L, Roder E, Rudofsky G, Wolfrum C (2011) Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans. Diabetologia 54:1468-1479
41. Prada PO, Ropelle ER, Mourao RH et al (2009) EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice. Diabetes 58:2910-2919
42. Landgraf K, Friebe D, Ullrich T et al (2012) Chemerin as a mediator between obesity and vascular inflammation in children. J Clin Endocrinol Metab 97:E556-E564
43. Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni PA (2002) Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J Clin Endocrinol Metab 87:4652-4656 (Pubitemid 35247056)
44. Zaldivar F, McMurray RG, Nemet D, Galassetti P, Mills PJ, Cooper DM (2006) Body fat and circulating leukocytes in children. Int J Obes (Lond) 30:906-911 (Pubitemid 43801189)
45. Basoni C, Nobles M, Grimshaw A et al (2005) Inhibitory control of TGF-beta1 on the activation of Rap1, CD11b, and transendothelial migration of leukocytes. FASEB J 19:822-824 (Pubitemid 40617396)
46. Han C, Jin J, Xu S, Liu H, Li N, Cao X (2010) Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat Immunol 11:734-742
47. Greiner T, Backhed F (2011) Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol Metab 22:117-123
48. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025 (Pubitemid 44684486)
49. Holland WL, Bikman BT, Wang LP et al (2011) Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 121:1858-1870